1 / 13

Watson for Oncology Clinical support 17.5

Watson for Oncology Clinical support 17.5. Tom Eggebraaten, 2017. Watson for Oncology – Cancer coverage. * 1 st Line Metastatic in this table refers to patients who are newly diagnosed with metastatic disease

jderek
Télécharger la présentation

Watson for Oncology Clinical support 17.5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Watson for Oncology Clinical support 17.5 Tom Eggebraaten, 2017

  2. Watson for Oncology – Cancer coverage * 1st Line Metastatic in this table refers to patients who are newly diagnosed with metastatic disease ** Med Onc: includes chemotherapy, endocrine therapy and targeted therapy where appropriate *** Ovarian also includes Fallopian Tube, and Primary Peritoneal cancer

  3. Watson Oncology – Unsupported cancer settings

  4. Watson Oncology – Colorectal cancer

  5. Watson Oncology – Lung cancer (Both Non-small cell and small cell histologies)

  6. Watson Oncology – Breast cancer

  7. Watson Oncology – Gastric cancer

  8. Watson Oncology – Cervical cancer

  9. * Ovarian also includes Fallopian Tube, and Primary Peritoneal cancer Watson Oncology – Ovarian cancer*

  10. Watson Oncology – Prostate cancer

  11. Watson Oncology – Decision tree New Patient Patient Age Colon < 18 Supported Rectal >= 18 Pregnant? Yes Not Supported Supported No No Multiple Cancers? Cancer Type? Lung Prior Surgery? Yes Not Supported Yes IIIB No Targeted 1 Multiple Primary Tumors? Number Of Metastatic Sites? Prior Therapy*? Yes Stage? IV 2+ No Local Recurrence? Chemo or None I - IIIA Supported Yes No Not Supported Adenoid cystic Colloid Secretory Tubular Male 2+ Breast # of Metastatic Therapies? Gender? Histology? M Category Female Other M1 Supported M0 0-1 Gastric, Cervical, Ovarian (Next chart) * Prior therapy includes: chemotherapy, radiation therapy, targeted therapy or endocrine therapy

  12. Watson Oncology – Decision tree Cancer Type Not Supported # of Metastatic Therapies? M Category Gastric 2+ M1 Supported M0 0 - 1 other Not Supported 3+ Squamous cell Adenocarcinoma Adenosquamous Small cell Gastric type Small cell # of Metastatic Therapies? Cervical Histology Cancer stage Histology 2 other IVB Supported I-IVA 0 - 1 other Not Supported 4+ # of Metastatic Therapies? Ovarian Histology Cancer stage High grade serous IV Supported I-III 0 - 3

  13. Watson Oncology – Decision tree Cancer Type other Not Supported 3+ # of Metastatic Therapies? Prostate Histology Adenocarcinoma Supported 0 - 2

More Related